Abstract
In the last 25 years, intestinal transplantation moved from an experimental procedure to an established treatment option for patients with irreversible intestinal failure and life-threatening complication of total parenteral nutrition. Intestinal transplantation is the only treatment that can potentially cure the baseline disease and reestablish the normal physiology and anatomy for those patients (Abu-Elmagd, Gastroenterology 130:132–137, 2006). Over the last 20 years, there have been significant advances in immunosuppression regimens leading to excellent short-term outcomes. However, chronic rejection persists as one of the major causes of graft loss (Grant et al, Ann Surg 241:607–613, 2005). A more complete understanding of the intestinal immunology and its association with graft failure continues to evolve. In addition to the immunological risks, intestinal retransplantation is one of the most challenging surgical procedures in the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abu-Elmagd K, Reyes J, Todo S et al (1998) Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 186(5):512–525
Abu-Elmagd K, Wu G, Costa G et al (2012) Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant 12(11):3047–3060
Beduschi T, Garcia J, Tekin A et al (2015) Multivisceral transplantation without an ostomy- experience with 15 patients [abstract]. Am J Transplant 15(Suppl 3):231
Bhamidimarri KR, Beduschi T, Vianna R (2014) Multivisceral transplantation: where do we stand? Clin Liver Dis 18(3):661–674
Cheng EY, Kaneku H, Farmer DG (2014) The role of donor-specific antibodies in intestinal transplantation: experience at the University of California Los Angeles an literature review. Clin Transpl 153–159 Review.PMID:26281140
Desai CS, Khan KM, Gruessner AC et al (2012) Intestinal retransplantation: analysis of Organ Procurement and Transplantation Network database. Transplantation 93(1):120–125
Fan J, Tekin A, Nishida S et al (2012) Preoperative embolization of the graft superior mesenteric artery assists graft enterectomy in intestinal transplant recipients. Transplantation 94(1):89–91
Garcia J, Beduschi T, Biaggi C et al (2015) Immunodeficiency assessment in pediatric intestinal failure patients [abstract]. Am J Transplant 15(Suppl 3):196
Grant W (2008) Surgical complications of intestinal transplantation. In: Langnas A (ed) Intestinal failure: diagnosis, management and transplantation. Blackwell, London
Hawksworth JS, Rosen-Bronson S, Island E et al (2012) Successful isolated intestinal transplantation in sensitized recipients with the use of virtual crossmatching. Am J Transplant 12(Suppl 4):S33–S42
Jabbour N, Reyes J, Todo S et al (1996) Intestinal retransplantation. Transplant Proc 28(5):2773–2774
Jugie M, Canioni D, Le Bihan C et al (2006) Study of the impact of the liver transplantation on the outcome of intestinal graft in children. Transplantation 81:992
Kanakry JA, Ambinder RF (2013) EBV-related lymphomas: new approaches to treatment. Curr Treat Options 14(2):224–236
Kato T, Berho M, Weppler D et al (2000) Is severe rejection an indication for retransplantation? Transplant Proc 32:1201
Mangus R, Kubal CA, Tector AJ et al (2012) Closure of the abdominal wall with acellular dermal allograft in intestinal transplantation. Am J Transplant 12(Suppl 4):S55–S59
Mazariegos G, Soltys K, Bond G et al (2008) Pediatric intestinal retransplantation: techniques, management, and outcomes. Transplantation 86(12):1777–1782
Nagai S, Mangus R, Ekser B et al (2015) Allograft enterectomy as a life-saving procedure and salvage for retransplantation [abstract]. Am J Transplant 15(Suppl 3):467
Nishida S, Komokata T, Ogata S et al (1998) Small bowel rejection in isolated small bowel transplantation and in multivisceral transplantation: a comparative study in a large animal model. In Vivo 12(2):259–266
Parizhskaya M, Redondo C, Demetris A et al (2003) Chronic rejection of small bowel grafts: pediatric and adult study of risk factors and morphology progression. Pediatr Dev Pathol 6:240–250
Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody, history and mechanism of action. Am J Transplant 6:859–866
Quintini C, Kato T, Gaynor JJ et al (2006) Analysis of risk factors for the development of posttransplant lymphoproliferative disorder among 119 children who received primary intestinal transplant at a single center. Transplant Proc 38:1755–1758
Selvaggi G, Gaynor JJ, Moon J et al (2007) Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience. Am J Transplant 7(5):1249–1257
Takahashi H, Selvaggi G, Nishida S et al (2006) Organ specific differences in acute rejection intensity in a multivisceral transplant. Transplantation 81(2):297–299
Wu G, Cruz RJ (2015) Liver inclusion improves outcomes of intestinal retransplantation in adults. Transplantation 99(6):1265–1272
Ziring D, Tran R, Edelstein S et al (2005) Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation 79:702–709
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Vianna, R., Beduschi, T. (2018). Intestine Retransplantation in the Intestine or Liver-Intestine Recipient. In: Dunn, S., Horslen, S. (eds) Solid Organ Transplantation in Infants and Children. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-07284-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-07284-5_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07283-8
Online ISBN: 978-3-319-07284-5
eBook Packages: MedicineReference Module Medicine